Evidence map›Paper›PMID 28261300›Full record

ArticleArchives of medical science : AMS2017

The impact of the Polish mass breast cancer screening program on prognosis in the Pomeranian Province.

Piotr Woźniacki, Jarosław Skokowski, Krzystof Bartoszek, Anna Kosowska, Leszek Kalinowski, Janusz Jaśkiewicz

Open access · goldAbstract read
In one paragraph

Article in Archives of medical science : AMS, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Piotr WoźniackiDepartment of Oncological Surgery, Medical University of Gdansk, Gdansk, Poland.
Jarosław SkokowskiDepartment of Oncological Surgery, Medical University of Gdansk, Gdansk, Poland.
Krzystof BartoszekDepartment of Mathematics, Uppsala University, Uppsala, Sweden.
Anna KosowskaDepartment of Oncological Surgery, Medical University of Gdansk, Gdansk, Poland.
Leszek KalinowskiDepartment of Medical Laboratory Diagnostics and Bank of Frozen Tissues and Genetic Specimens, Medical University of Gdansk, Gdansk, Poland.
Janusz JaśkiewiczDepartment of Oncological Surgery, Medical University of Gdansk, Gdansk, Poland.
Gdańsk Medical University · PLUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMammographic screening results in diagnosis of less advanced breast cancer (BC). A meta-analysis of randomized clinical trials confirmed that BC screening reduces mortality. In 2007, the National Breast Cancer Screening Program (NBCSP) was established in Poland with the crucial aim of reducing mortality from BC. The purpose of this study was to assess the impact of participation in the NBCSP on prognosis. MATERIAL AND

methodsA single institution, non-randomized retrospective study was undertaken. The study population comprised 643 patients with BC treated in the Department of Surgical Oncology (DSO) at the Medical University of Gdansk over a 4-year period, from 01.01.2007 until 31.12.2010. Patients were divided into two groups: group A - patients who participated in the NBCSP (

resultsStatistical analysis revealed that group A displayed a less advanced AJCC stage (more patients in AJCC stage I,

conclusionsThe study results revealed the beneficial impact of the NBCSP. Superior prognostic factors and favorable staging were observed in women who participated in the NBCSP.

Indexed as

AJCC stagingbreast cancermass screeningprognosisprognostic factorsscreening

Identifiers

PMID28261300
PMCPMC5332447
OpenAlexW2499186644

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.